Evidence map›Paper›PMID 39844752›Full record

ArticleHaematologica2025

Pre-phase treatment with rituximab and high-dose methotrexate to re-evaluate eligibility for intensive induction treatment of frail patients with central nervous system lymphoma.

Julia Wendler, Richard I Lewis, Alexandra Kutilina, Markus Knott, Lisa Kristina Isbell, Elke Valk, Peter Borchmann, Jan-Michel Heger, Gerald Illerhaus, Elisabeth Schorb

Abstract read
In one paragraph

Article in Haematologica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Julia WendlerClinic of Hematology, Oncology, Stem Cell Transplantation and Palliative Care, Klinikum Stuttgart, Stuttgart. j.wendler@klinikum-stuttgart.de.
Richard I LewisDepartment I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany; Cologne Lymphoma Working Group (CLWG), Cologne.
Alexandra KutilinaDepartment of Medicine I, Medical Center, Faculty of Medicine, University of Freiburg.
Markus KnottClinic of Hematology, Oncology, Stem Cell Transplantation and Palliative Care, Klinikum Stuttgart, Stuttgart.
Lisa Kristina IsbellDepartment of Medicine I, Medical Center, Faculty of Medicine, University of Freiburg.
Elke ValkStuttgart Cancer Center - Tumorzentrum Eva Mayr-Stihl, Stuttgart.
Peter BorchmannDepartment I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany; Cologne Lymphoma Working Group (CLWG), Cologne.
Jan-Michel HegerDepartment I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany; Cologne Lymphoma Working Group (CLWG), Cologne, Germany; Mildred Scheel School of Oncology Aachen Bonn Cologne Düsseldorf (MSSO ABCD), Cologne, Faculty of Medicine and University Hospital of Cologne, D-50937, Cologne.
Gerald IllerhausClinic of Hematology, Oncology, Stem Cell Transplantation and Palliative Care, Klinikum Stuttgart, Stuttgart.
Elisabeth SchorbDepartment of Medicine I, Medical Center, Faculty of Medicine, University of Freiburg.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39844752
PMCPMC12130764

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.